Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : 4-fluart Inactivated Influenza Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety of 4Fluart ID Suspension for Injection in Adult Subjects
Details : 4-fluart Inactivated Influenza Vaccine is a Vaccine drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Influenza, Human.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
February 28, 2018
Lead Product(s) : 4-fluart Inactivated Influenza Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Seasonal Influenza Virus Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Seasonal Influenza Virus Vaccine is a Vaccine drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Influenza, Human.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
March 13, 2015
Lead Product(s) : Seasonal Influenza Virus Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Seasonal Influenza Virus Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Tolerability and Immunogenicity Study of Fluval AB Suspension for Injection
Details : Seasonal Influenza Virus Vaccine is a Vaccine drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Influenza, Human.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
May 29, 2013
Lead Product(s) : Seasonal Influenza Virus Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fluval AB VAccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Fluval AB VAccine is a Vaccine drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Influenza, Human.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
July 25, 2012
Lead Product(s) : Fluval AB VAccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : FAB-6011
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : FAB-6011 is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Influenza, Human.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 25, 2011
Lead Product(s) : FAB-6011
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : FAB-6011
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : FAB-6011 is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Influenza, Human.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 03, 2011
Lead Product(s) : FAB-6011
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fluval P Monovalent Influenza Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Fluval P Monovalent Influenza Vaccine is a Vaccine drug candidate, which is currently being evaluated in clinical studies for the treatment of Influenza, Human.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
August 02, 2011
Lead Product(s) : Fluval P Monovalent Influenza Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fluval AB Influenza Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons
Details : Fluval AB Influenza Vaccine is a Vaccine drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Influenza, Human.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
July 27, 2011
Lead Product(s) : Fluval AB Influenza Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Seasonal Influenza Virus Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in Children
Details : Seasonal Influenza Virus Vaccine is a Vaccine drug candidate, which is currently being evaluated in clinical studies for the treatment of Influenza, Human.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
April 08, 2010
Lead Product(s) : Seasonal Influenza Virus Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
